• Reinhard L. Friede


The forms of sphingolipidoses described in the present chapter had in the past been classified into three disease entities: 1. Familial amaurotic idiocy was considered a lipid storage disease affecting the central nervous system only. 2. Gaucher and 3. Niemann-Pick diseases were thought to be generalized lipidoses with predominant visceral involvement. Amaurotic idiocy was subclassified according to its age of onset, as proposed by Vogt (1909) and amplified by later investigators: There was a congenital form (Norman-Wood), an infantile form (Tay-Sachs), a late infantile form (Bielschowsky Jansky), a juvenile form (for which the subtypes Spielmeyer-Vogt, Batten-Mayou, and Sjögren had been proposed), and an adult form (Kufs). All these types were assumed to be manifestations of one and the same disease. Prior to the chemical identification of the lipids stored in these diseases (and even for some time thereafter), there was considerable controversy on whether amaurotic idiocy was indeed an entity or merely a variant of Niemann-Pick disease in which lipid storage is restricted to the nervous system.


Gauche Disease Juvenile Form Infantile Form Gauche Cell Lipid Storage Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adachi, M., Schneck, L., Volk, B. W.: Ultrastructural studies of eight cases of fetal Tay-Sachs disease. Lab. Invest. 30: 102–112, 1974.PubMedGoogle Scholar
  2. Adachi, M., Torii, J., Karvounis, P. C., Volk, B. W.: Alterations of astrocytic organelles in various lipidoses and allied diseases. Acta neuropath. (Berl.) 18: 74–83, 1971.CrossRefGoogle Scholar
  3. Adachi, M., Wallace, B. J., Schneck, L., Volk, B. W.: Fine structure of the central nervous system in early infantile Gaucher’s disease. Arch. Path. (Chic.) 83: 513–526, 1967.Google Scholar
  4. Anzil, A. P., Blinzinger, K., Mehraein, P., Dozic, S.: Niemann-Pick disease type C: Case report with ultrastructural findings. Neuropädiatrie 4: 207–225, 1973.PubMedCrossRefGoogle Scholar
  5. Aronson, S. M., Volk, B. W., Epstein, N.: Morphologic evolution of amaurotic family idiocy. Amer. J. Path. 31: 609–631, 1955.PubMedGoogle Scholar
  6. Banker, B. Q., Miller, J. Q., Crocker, A. C.: The cerebral pathology of infantile Gaucher’s disease. In: Cerebral Sphingolipidoses (Aronson, S. M., Volk, B. W., eds.), pp. 73–99. New York: Academic Press 1962.Google Scholar
  7. Bérard-Badier, M., Payan, H., Edgar, W. F.: Etude histologique du système nerveux central d’un cas de maladie de Gaucher dans une fratrie. Proc. 4th Int. Congr. Neuropath., Munich 3: 102–108, 1961.Google Scholar
  8. Bernheimer, H., Karbe, E.: Morphologische und neurochemische Untersuchungen von 2 Formen der amaurotischen Idiotie des Hundes. Nachweis einer GM 2-Gangliosidose. Acta neuropath. (Berl.) 16: 243–261, 1970.CrossRefGoogle Scholar
  9. Bernheimer, H., Seitelberger, F.: Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spätinfantiler amaurotischer Idiotie. Wien. klin. Wschr. 80: 163–164, 1968.PubMedGoogle Scholar
  10. Bielschowsky, M.: Amaurotische Idiotie und lipoidzellige Splenohepatomegalie. J. Psychol. Neurol. (Lpz.) 36: 103–123, 1928.Google Scholar
  11. Bernheimer, H., Johnson, W. G., Uhlendorf, B. W.: Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications. Amer. J. Med. 51: 423–431, 1971.CrossRefGoogle Scholar
  12. Bernheimer, H., Kanfer, J. N., Bradley, R. M., Shapiro, D.: Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher’s disease. J. clin. Invest. 45: 1112–1115, 1966CrossRefGoogle Scholar
  13. Bernheimer, H., Kanfer, J. N., Mock, M. B., Fredrickson, D. S.: The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc. nat. Acad. Sci. (U.S.A.) 55: 366–369, 1966.CrossRefGoogle Scholar
  14. Bernheimer, H., Kanfer, J. N., Shapiro, D.: Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem. biophys. Res. Commun. 18: 221–225, 1965.Google Scholar
  15. Brett, E. M., Ellis, R. B., Haas, L., et al.: Late onset GM2-gangliosidosis: clinical, pathological, and biochemical studies on 8 patients. Arch. Dis. Child. 48: 775–785, 1973.PubMedCrossRefGoogle Scholar
  16. Burne, J. C.: Niemann-Pick disease in a foetus. J. Path. Bact. 66: 473–477, 1953.PubMedCrossRefGoogle Scholar
  17. Crocker, A.: The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J. Neurochem. 7: 69–80, 1961.PubMedCrossRefGoogle Scholar
  18. Crocker, A. C., Farber, S.: Niemann-Pick disease: a review of eighteen patients. Medicine 37: 1–95, 1958.PubMedCrossRefGoogle Scholar
  19. Crocker, A., Mays, V. B.: Sphingomyelin synthesis in Niemann-Pick disease. Amer. J. clin. Nutr. 9: 63–67, 1961.PubMedGoogle Scholar
  20. Cumings, J. N.: Abnormalities in lipid metabolism in two members of a family with Niemann-Pick disease. In: Cerebral Sphingolipidoses (Aronson, S. M., Volk, B. W., eds.), pp. 171–178. New York: Academic Press 1962.Google Scholar
  21. Cutz, E., Lowden, J. A., Conen, P. E.: Ultrastructural demonstration of neuronal storage in fetal Tay-Sachs disease. J. Neurol. Sci. 21: 197–202, 1974.PubMedCrossRefGoogle Scholar
  22. Debré, R., Bertrand, I., Grumbach, R., Bargeton, E.: Maladie de Gaucher du nourrisson. Arch. franç. Pédiat. 8: 38–42, 1951.PubMedGoogle Scholar
  23. De Marsh, Q. B., Kantz, J.: The submicroscopic morphology of Gaucher cells. Blood 12: 324–335, 1957.Google Scholar
  24. Derry, D. M., Fawcell, J. S., Andermann, F., Wolfe, L. S.: Late infantile systemic lipidosis. Neurology (Minneap.) 18: 340–348, 1968.CrossRefGoogle Scholar
  25. Diezel, P. B.: Histochemische Untersuchungen an primären Lipoidosen: Amaurotische Idiotie, Gargoylismus, Niemann-Picksche Krankheit, Gauchersche Krankheit, mit besonderer Berücksichtigung des Zentralnervensystems. Virchows Arch. 326: 89–118, 1954.PubMedCrossRefGoogle Scholar
  26. Dolman, C. L., Chang, E., Duke, R. J.: Pathologic findings in Sandhoff disease. Arch. Path. 96: 272–275, 1973.PubMedGoogle Scholar
  27. Donnelly, W. J. C., Sheahan, B. J., Rogers, T. A.: GM1gangliosidosis in Friesian calves. J. Path. 111: 173–180, 1973.PubMedCrossRefGoogle Scholar
  28. Eeg-Olofson, O., Kristensson, K., Sourander, P., Svennerholm, L.: Tay-Sachs disease; a generalized metabolic disorder. Acta pediat. scand. 55: 546–562, 1966.CrossRefGoogle Scholar
  29. Epstein, C. J., Brady, R. O., Schneider, E. L., et al.: In utero diagnosis of Niemann-Pick disease. Amer. J. hum. Genet. 23: 533–535, 1971.PubMedGoogle Scholar
  30. Farrell, D. F., Baker, H. J., Herndon, R. M., Lindsey, J. R., McKhann, G. M.: Feline GM1gangliosidosis: Biochemical and ultrastructural comparisons with the disease in man. J. Neuropath. exp. Neurol. 32: 1–18, 1973.PubMedCrossRefGoogle Scholar
  31. Fredrickson, D. S., Sloan, H. R.: Sphingomyelin lipidoses: Niemann-Pick disease. In: The Metabolic Basis of Inherited Disease (Stanbury, J. B., Wyngarden, J. B., Fredricksen, D. S., eds.), Third Edition, Chapter 35. New York: McGraw-Hill 1972.Google Scholar
  32. Friede, R. L., Allen, R. J.: Enzyme histochemical studies of Tay-Sachs disease. J. Neuropath. exp. Neurol. 23: 619–634, 1964.PubMedCrossRefGoogle Scholar
  33. Bernheimer, H., Kanfer, J. N., Baird, H. W., Evangelista, I.: The fine structure of neocortical synapses in infantile amaurotic idiocy. J. Neuropath. exp. Neurol. 27: 39–49, 1968.CrossRefGoogle Scholar
  34. Bernheimer, H., Kanfer, J. N., Gonatas, J.: Ultrastructural and biochemical observations on a case of systemic late infantile lipidosis and its relationship to Tay-Sachs disease and gargoylism. J. Neuropath. exp. Neurol. 24: 318–340, 1965.CrossRefGoogle Scholar
  35. Gumbinas, M., Larsen, M., Mei Liu, H.: Peripheral neuropathy in classic Niemann-Pick disease. Neurol. 25: 107–113, 1975.CrossRefGoogle Scholar
  36. Haberland, C., Brunngraber, E. G.: Early infantile neurolipidosis with failure of myelination. A chemical and histopathological study. Arch. Neurol. (Chic.) 23: 481–488, 1970.CrossRefGoogle Scholar
  37. Haberland, C., Brunngraber, E., Witting, L., Brown, B.: The white matter in GM2-gangliosidosis. A comparative histopathological and biochemical study. Acta neuropath. (Berl.) 24: 43–55, 1973.CrossRefGoogle Scholar
  38. Halliday, N., Deuel, H. J., Tragerman, L. J., Ward, W. E.: On the isolation of a glucosecontaining cerebroside from spleen in a case of Gaucher’s disease. J. Biol. Chem. 132: 171–180, 1940.Google Scholar
  39. Hernandez, F., Bueno, M.: Infantile neurological Gaucher’s disease in three siblings. An ultrastructural study. Virchows Arch. path. Anat. 360: 27–32, 1973.Google Scholar
  40. Herrlin, K. M., Hillborg, P.: Neurologic signs in juvenile Gaucher’s disease. Acta paediat. (Uppsala) 51: 137–154, 1962.CrossRefGoogle Scholar
  41. Heyne, K., von der Linde, J., Trubsbach, A.: Die Lungenerkrankung bei generalisierter G M1-Gangliosidose. Helv. paediat. Acta 27: 591–600, 1972.PubMedGoogle Scholar
  42. Hibbs, R. G., Ferrans, V. J., Cipriano, P. R., Tardiff, K. J.: A histochemical and electron microscopic study of Gaucher cells. Arch. Path. (Chic.) 89: 137–153, 1970.Google Scholar
  43. Hillborg, P. O., Svennerholm, L.: Blood level of cerebrosides in Gaucher’s disease. Acta paediat. (Uppsala) 49: 707–710, 1960.CrossRefGoogle Scholar
  44. Ho, M. W., Seck, J., Schmidt, D., et al.: Adult Gaucher’s disease: Kindred studies and demonstration of a deficiency of acid β-glucosidase in cultured fibroblasts. Amer. J. hum. Genet. 24: 37–45, 1972.PubMedGoogle Scholar
  45. Hsia, D. Y. Y., Naylor, J., Bigler, J. A.: The genetic mechanism of Gaucher’s disease. In: Cerebral Sphingolipidoses (Aronson, S. M., Volk, B. W., eds.), pp. 327–342. New York: Academic Press 1962.Google Scholar
  46. Jatzkewitz, H., Sandhoff, K.: On a biochemically special form of infantile amaurotic idiocy. Biochim. biophys. Acta 70: 354–356, 1963.PubMedCrossRefGoogle Scholar
  47. Jervis, G. A., Harris, R. G., Menkes, J. H.: Cerebral lipidosis of unclear nature. In: Cerebral sphingolipidoses (Aronson, S. M., Volk, B. W., eds.), pp. 101–123. New York: Academic Press 1962.Google Scholar
  48. Jørgensen, L., Blackstad, T. W., Hallmark, W., Steen, J. A.: Niemann-Pidk’s disease. Report of a case with histochemical evidence of neuronal storage of acid glycolipids. Acta neuropath. (Berl.) 4: 90–106, 1964.CrossRefGoogle Scholar
  49. Juif, J.-G., Luckel, J.-C., Nußbaum, J.-L., et al.: La gangliosidose GM 2 avec déficit complet en β-N-acetyl-hexosaminidase ou maladie de Sandhoff. Arch. franç. Pédiat. 30: 29–43, 1973.PubMedGoogle Scholar
  50. Kamoshita, S., Aron, A. M., Suzuki, K., Suzuki, K.: Infantile Niemann-Pick disease. Amer. J. Dis. Child. 117: 379–394, 1969.PubMedGoogle Scholar
  51. Klenk, E.: Über die Natur der Phosphatide der Milz bei der Niemann-Pickschen Krankheit. Hoppe Seyler Z. Physiol. Chem. 229: 151–156, 1934.CrossRefGoogle Scholar
  52. Klenk, E.: Über die Natur der Phosphatide und anderen Lipoide des Gehirns und der Leber bei der Niemann-Pickschen Krankheit. Hoppe Seyler Z. Physiol. Chem. 235: 24–36, 1935.CrossRefGoogle Scholar
  53. Klenk, E.: Niemann-Picksche Krankheit und amaurotische Idiotie. Hoppe Seyler Z. Physiol. Chem. 262: 128–143, 1939.CrossRefGoogle Scholar
  54. Klenk, E.: Über die Ganglioside des Gehirns bei der infantilen amaurotischen Idiotie vom Typ Tay-Sachs. Ber. dtsch. chem. Ges. 75: 1632–1636, 1942.CrossRefGoogle Scholar
  55. Rennkamp, F.: Der Zucker im Cerebrosid der Milz bei der Gaucher-Krankheit. Z. physiol. Chem. 272: 272–280, 1942.Google Scholar
  56. Klibansky, C., Saifer, A., Feldman, N. I., et al.: Cerebral lipids in a case of systemic GM 2-gangliosidosis of a late infantile type. J. Neurochem. 17: 339–346, 1970.PubMedCrossRefGoogle Scholar
  57. Landing, B. H., Silverman, F. N., Craig, J. M., et al.: Familial neurovisceral lipidosis. Amer. J. Dis. Child. 108: 503–522, 1964.PubMedGoogle Scholar
  58. Lazarus, S. S., Vethamay, V. G., Schneck, L., Volk, B. W.: Fine structure and histochemistry of peripheral blood cells in Niemann-Pick disease. Lab. Invest. 17: 155–170, 1967.PubMedGoogle Scholar
  59. Lazarus, S. S., Wallace, B. J., Volk, B. W.: Neuronal enzyme alterations in Tay-Sachs disease. Amer. J. Path. 41: 579–591, 1962.PubMedGoogle Scholar
  60. Ledeen, R., Salsman, K.: Structure of the Tay-Sachs’ ganglioside. Biochemistry (Wash.) 4: 2225–2233, 1965.CrossRefGoogle Scholar
  61. Ledeen, R., Salsman, K., Gonatas, J., Tachavy, A.: Structure comparison of the major monosialogangliosides from brains of normal human, gargoylism and late infantile systemic lipidosis. J. Neuropath. exp. Neurol. 24: 341–351, 1965.PubMedCrossRefGoogle Scholar
  62. Lee, R. E.: The fine structure of the cerebroside occurring in Gaucher’s disease. Proc. nat. Acad. Sci. (U.S.A.) 61: 484–489, 1968.CrossRefGoogle Scholar
  63. Lee, R. E., Balcerzak, S. P., Westerman, M. P.: Gaucher’s disease. Amer. J. Med. 42: 891–898, 1967.PubMedCrossRefGoogle Scholar
  64. Levine, S., Hoenig, E. M.: Astrocytic gliosis of vascular adventitia in arachnoid membrane in infantile Gaucher’s disease. J. Neuropath. exp. Neurol. 31: 147–156, 1972.PubMedCrossRefGoogle Scholar
  65. Lieb, H.: Cerebrosidspeicherung bei Splenomegalie, Typus Gaucher. Z. physiol. Chem. (Hoppe Seyler) 140: 305–313, 1924.CrossRefGoogle Scholar
  66. Lowden, J. A., Cutz, E., Conen, P. E., et al.: Prenatal diagnosis of GM1gangliosidosis. New Engl. J. Med. 288: 225–228, 1973.PubMedCrossRefGoogle Scholar
  67. Lowden, J. A., Callahan, J. W., Norman, M. G., et al.: Juvenile GMn- gangliosidosis. Arch. Neurol. 31: 200–203, 1974.PubMedCrossRefGoogle Scholar
  68. Lynn, R., Terry, R. D.: Lipid histochemistry and electron microscopy in adult Niemann-Pick disease. Amer. J. Med. 37: 987–994, 1964.PubMedCrossRefGoogle Scholar
  69. MacBrinn, M. C., Okada, S., Ho, M. W., et al.: Generalized gangliosidosis: impaired cleavage of galactose from a mucopolysaccharide and a glycoprotein. Science 163: 946–947, 1969.PubMedCrossRefGoogle Scholar
  70. Maloney, A. F. J., Cumings, J. N.: A case of juvenile Gaucher’s disease with intraneuronal lipid storage. J. Neurol. Neurosurg. Psychiat. 23: 207–213, 1960.PubMedCrossRefGoogle Scholar
  71. Martin, J.-J., Philippart, M., Van Hauwaert, J., et al.: Niemann-Pick disease (Crocker’s group A). Late onset and pigmentary degeneration resembling Hallervorden-Spatz syndrome. Arch. Neurol. (Chic.) 27: 45–51, 1972.CrossRefGoogle Scholar
  72. Menkes, J. H., O’Brien, J. S., Okada, S., et al.: Juvenile G M2-gangliosidosis. Arch. Neurol. (Chic.) 25: 14–22, 1971.CrossRefGoogle Scholar
  73. Mihatsch, M. J., Ohnacker, H., Riede, U. N., et al.: GM1-gangliosidosis. Helv. paediat. Acta 28: 521–542, 1973.PubMedGoogle Scholar
  74. Milunski, A., Littlefield, J. W., Kanfer, J. N., et al.: Prenatal genetic diagnosis. New Engl. J. Med. 283: 1370–1381; 1441–1447; 1498–1504, 1970.CrossRefGoogle Scholar
  75. Norman, R. M.: Niemann-Pick disease. In: Handbook of Clinical Neurology (Vinken, P. J., Bruyn, G. W., eds.), Vol. 10, pp. 484–508. Amsterdam: North Holland 1970.Google Scholar
  76. Norman, R. M.: Gaucher’s disease. In: Handbook of Clinical Neurology (Vinken, P. J., Bruyn, G. W., eds.), Vol. 10, pp. 509–531.Google Scholar
  77. Norman, R. M.: Forrester, R. M., Tingey, A. H.: The juvenile form of Niemann-Pick disease. Arch. Dis. Child. 42: 91–96, 1967.PubMedCrossRefGoogle Scholar
  78. Norman, R. M.: Tingey, A. H., Newman, C. G. H., Ward, S.: Tay-Sachs disease with visceral involvement and its relation to gargoylism. Arch. Dis. Child. 39: 634–640, 1964.PubMedCrossRefGoogle Scholar
  79. Norman, R. M., Urich, H., Lloyd, O. L.: The neuropathology of infantile Gaucher’s disease. J. Path. Bact. 72: 121–131, 1956.PubMedCrossRefGoogle Scholar
  80. Norman, R. M., Tingey, H. H., Goodbody, R. A.: Tay-Sachs’ disease with visceral involvement and its relationship to Niemann-Pick’s disease. J. Path. Bact. 78: 409–421, 1959.PubMedCrossRefGoogle Scholar
  81. O’Brien, J.: Generalized gangliosidosis. J. Pediat. 75: 167–186, 1969.PubMedCrossRefGoogle Scholar
  82. O’Brien, J. S., Okada, S., Chen, A., Fillerup, D. L.: Tay-Sachs disease. Detection of heterozygotes by serum hexosaminidase assay. New Engl. J. Med. 283: 15–20, 1970.PubMedCrossRefGoogle Scholar
  83. O’Brien, J. S., Stern, M. B., Landing, B. H., et al.: Generalized gangliosidosis. Amer. J. Dis. Child. 109: 338–346, 1965.PubMedGoogle Scholar
  84. Okada, S., O’Brien, J. S.: Tay-Sachs disease: generalized absence of a Beta-D-N-acetylhexosaminidase component. Science 165: 698–700, 1969.PubMedCrossRefGoogle Scholar
  85. Okada, S., McCrea, M., O’Brien, J. S.: Sandhoff’s disease (G M2-gangliosidosis type 2): Clinical, chemical, and enzyme studies in five patients. Pediat. Res. 6: 606–615, 1972.PubMedGoogle Scholar
  86. Okada, S., Veath, M. L., O’Brien, J. S.: Juvenile GM2-gangliosidosis: partial deficiency of hexosaminidase A. J. Pediat. 77: 1063–1064, 1970.PubMedCrossRefGoogle Scholar
  87. Patton, V. M., Dekaban, S. S.: GM1-gangliosidosis and juvenile cerebral lipidosis. Clinical, histochemical, and chemical study. Arch. Neurol. (Chic.) 24: 529–537, 1971.CrossRefGoogle Scholar
  88. Pilz, H., Jatzkewitz, H.: Düinnschichtchromatographische Bestimmungen von C18 und C24 Sphingomyelin in normalen und pathologischen Gehirnen einschließlich eines Falles von Niemann-Pickscher Erkrankung. J. Neurochem. 11: 603–611, 1964.PubMedCrossRefGoogle Scholar
  89. Pilz, H., Jatzkewitz, Sandhoff, K., Jatzkewitz, H.: Eine Gangliosidstoffwechselstörung mit Anhäufung von Ceramid-lactosid, monosialo ceramid-lactosid und Tay-Sachs-gangliosid im Gehirn. J. Neurochem. 13: 1273–1282, 1966.PubMedCrossRefGoogle Scholar
  90. Roels, H., Quatacker, J., Kint, A., et al.: Generalized gangliosidosis—GM1 (Landing disease). II. Morphological study. Europ. Neurol. 3: 129–160, 1970.PubMedCrossRefGoogle Scholar
  91. Rosenberg, A.: The sphingolipids from the spleen of a case of lipidosis. In: Cerebral sphingolipidoses (Aronson, S. M., Volk, B. W., eds.), pp. 119–123. New York: Academic Press 1962.Google Scholar
  92. Rouser, G., Feldman, G., Galli, C.: Fatty acid compositions of human brain lecithin and sphingomyelin in normal individuals, senile cerebral cortical atrophy, Alzheimer’s disease, metachromatic leucodystrophy, Tay-Sachs and Niemann-Pick disease. J. Amer. Oil Chem. Soc. 42: 411–412, 1965.CrossRefGoogle Scholar
  93. Sachs, B.: A family form of idiocy, generally fatal, associated with early blindness (amaurotic family idiocy). J. nerv. ment. Dis. 23: 475–479, 1896.Google Scholar
  94. Sacrez, R., Juif, J. G., Gigonnet, J. M., et al.: La maladie de Landing: ou idiotie amaurotique infantile précoce avec gangliosidose généralisée de type GM1. Pediatrie 22: 143–162, 1967.PubMedGoogle Scholar
  95. Samuels, S., Gonatas, N. K., Weiss, M.: Chemical and ultrastructural comparison of synthetic and pathologic membrane system. J. Cell Biol. 21: 148–152, 1964.PubMedCrossRefGoogle Scholar
  96. Samuels, S., Korey, S. R., Gonatas, J., et al.: Studies in Tay-Sachs disease. IV. Membranous cytoplasmic bodies. J. Neuropath. exp. Neurol. 22: 81–97, 1963.PubMedCrossRefGoogle Scholar
  97. Sandhoff, K., Andreae, U., Jatzkewitz, H.: Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci. 7: 283–288, 1968.PubMedCrossRefGoogle Scholar
  98. Sandhoff, K., Harzer, K., Wässle, W., Jatzkewitz, H.: Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18: 2469–2489, 1971.PubMedCrossRefGoogle Scholar
  99. Schaffer, K.: Zur Pathogenese der Tay-Sachs’schen amaurotischen Idiotie. Neurol. Centralbl. 24: 386–392; 437–448, 1905.Google Scholar
  100. Schairer, E.: Die Gehirnveränderungen beim Morbus Gaucher des Säuglings. Virchows Arch. path. Anat. 315: 395–406, 1948.Google Scholar
  101. Scherer, H. J.: Die Ammonshornveränderungen bei der familiären amaurotischen Idiotie. Z. Neur. 138: 481–492, 1932.Google Scholar
  102. Schneider, E. L., Ellis, W. G., Brady, R. O., et al.: Prenatal Niemann-Pick disease: Biochemical and histologic examination of a 19-gestational week fetus. Pediat. Res. 6: 720–729, 1972.PubMedGoogle Scholar
  103. Schneider, E. L., Ellis, W. G., Brady, R. O., et al.: Infantile (type II) Gaucher’s disease: In utero diagnosis and fetal pathology. J. Pediat. 81: 1134–1139, 1972.PubMedCrossRefGoogle Scholar
  104. Schneider, P. B., Kennedy, E. P.: Sphingomyelinase in normal spleens and the spleens from subjects with Niemann-Pick disease. J. Lipid Res. 8: 202–209, 1967.PubMedGoogle Scholar
  105. Seitelberger, F.: Über Gehirnbeteiligung bei der Gaucherschen Krankheit im Kindesalter. Arch. Psychiat. Nervenkr. 206: 419–440, 1964.CrossRefGoogle Scholar
  106. Severi, F., Magrini, U., Tettamanti, G., et al.: Infantile GM 1 gangliosidosis. Histochemical, ultrastructural and biochemical studies. Helv. paediat. Acta 26: 192–209, 1971.PubMedGoogle Scholar
  107. Singer, H. S., Nankervis, G. A., Schafer, I. A.: Leukocyte beta-galactosidase activity in the diagnosis of generalized GM1-gangliosidosis. Pediatrics 49: 352–361, 1972.PubMedGoogle Scholar
  108. Sloan, H. R., Uhlendorf, B. W., Jacobsen, C. B., et al.: β-galactosidase in tissue culture derived from human skin and bone marrow: enzyme defect in GM1gangliosidosis. Pediat. Res. 3: 532–537, 1969.PubMedCrossRefGoogle Scholar
  109. Snyder, P. D., Jr., Krivit, W., Sweeley, C. C.: Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. J. Lipid Res. 13: 128–136, 1972.PubMedGoogle Scholar
  110. Stern, J.: The induction of ganglioside storage in nervous system cultures. Lab. Invest. 26: 509–514, 1972.PubMedGoogle Scholar
  111. Suzuki, K., Suzuki, K., Chen, G. C.: Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis). J. Neuropath. exp. Neurol. 27: 15–38, 1968.PubMedCrossRefGoogle Scholar
  112. Suzuki, K., Suzuki, K., Kamoshita, S.: Chemical pathology of GM1-gangliosidosis. J. Neuropath. exp. Neurol. 28: 25–73, 1969.PubMedCrossRefGoogle Scholar
  113. Suzuki, K., Suzuki, K., Rapin, I., et al.: Juvenile GM2-gangliosidosis: Clinical variant of Tay-Sachs disease or a new disease. Neurology (Minneap.) 20: 190–204, 1970.CrossRefGoogle Scholar
  114. Suzuki, Y., Crocker, A., Suzuki, K.: GM1-gangliosidosis. Correlation of clinical and biochemical data. Arch. Neurol. (Chic.) 24: 58–64, 1971.CrossRefGoogle Scholar
  115. Suzuki, Y., Jacob, J. C., Suzuki, K., et al.: GM2-gangliosidosis with total hexosaminidase deficiency. Neurology (Minneap.) 21: 313–328, 1971.CrossRefGoogle Scholar
  116. Suzuki, Y., Suzuki, K.: Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis. Neurology (Minneap.) 20: 848–851, 1970.CrossRefGoogle Scholar
  117. Svennerholm, L.: The chemical structure of normal human brain and Tay-Sachs gangliosides. Biochem. biophys. Res. Commun. 5: 436–441, 1962.CrossRefGoogle Scholar
  118. Svennerholm, L., Sourander, P.: Investigations on brain autopsy material in lipidoses. Proc. 5th Int. Congr. Neuropath. Zürich. Excerpta Med. Foundation, Amsterdam 1966, pp. 342–349.Google Scholar
  119. Tanaka, Y., Brecher, G., Fredrickson, D. S.: Cellules de la maladie de Niemann-Pick et de quelques autres lipoidoses. Nouv. Rev. franç. Hémat. 3: 5–16, 1963.PubMedGoogle Scholar
  120. Tay, W.: Symmetrical changes in the region of the yellow spot in each eye of an infant. Trans. ophthal. Soc. U.K. 1: 55–57, 1881.Google Scholar
  121. Terry, R. D., Korey, S. R.: Membranous cytoplasmic granules in infantile amaurotic idiocy. Nature 188: 1000–1002, 1960.PubMedCrossRefGoogle Scholar
  122. Terry, R. D., Weiss, M.: Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. J. Neuropath. exp. Neurol. 22: 18–55, 1963.PubMedCrossRefGoogle Scholar
  123. Themann, H., Diekmann, L., v. Bassewitz, D. B.: Die Feinstruktur der menschlichen Leber bei generalisierter Gangliosidose GM1. Beitr. path. Anat. 140: 194–211, 1970.Google Scholar
  124. Trams, E. G., Brady, R. O.: Cerebroside synthesis in Gaucher’s disease. J. clin. Invest. 39: 1546–1550, 1960.PubMedCrossRefGoogle Scholar
  125. Uzman, L. L.: The lipoprotein of Gaucher’s disease. Arch. Path. (Chic.) 51: 329–339, 1951.Google Scholar
  126. Vidailhet, M., Neimann, N., Grigon, G., et al.: Maladie de Sandhoff (gangliosidose A GM 2, de type 2). Etude clinique, biochimique et anatomo-pathologique. Arch. franç. Pédiat. 30: 45–60, 1973.PubMedGoogle Scholar
  127. Vogt, H.: Familiäre amaurotische Idiotie, histologische und histopathologische Studien. Arch. Kinderheilk. 51: 1–35, 1909.Google Scholar
  128. Volk, B. W., Adachi, M., Schneck, L., et al.: G5-ganglioside variant of systemic late infantile lipidosis. Arch. Path. (Chic.) 87: 393–403, 1969.Google Scholar
  129. Volk, B. W., Wallace, B. J.: The liver in lipidosis. Amer. J. Path. 49: 203–226, 1966.PubMedGoogle Scholar
  130. Wallace, B. J., Schneck, L., Kaplan, H., Volk, B. W.: Fine structure of the cerebellum of children with lipidoses. Arch. Path. (Chic.) 80: 466–486, 1965.Google Scholar
  131. Wallace, B. J., Volk, B. W., Lazarus, S. S.: Fine structural localization of acid phosphatase activity in neurons of Tay-Sachs disease. J. Neuropath. exp. Neurol. 23: 676–692, 1964.PubMedCrossRefGoogle Scholar
  132. Wallace, B. J., Volk, B. W., Schneck, L., Kaplan, H.: Fine structural localization of two hydrolytic enzymes in the cerebellum of children with lipidoses. J. Neuropath. exp. Neurol. 25: 76–96, 1966.CrossRefGoogle Scholar
  133. Wolfe, L. S., Callahan, J., Fawcett, J. S., et al.: GM1gangliosidosis without chondrodystrophy or visceromegaly. B-galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate. Neurology (Minneap.) 20: 23–44, 1970.CrossRefGoogle Scholar
  134. Wolman, M.: A histochemical study of various forms of cerebral lipidoses. J. clin. Path. 15: 324–327, 1962.PubMedCrossRefGoogle Scholar
  135. Zeman, W., Dyken, P.: Neuronal ceroid-lipofuscinosis (Batten’s disease): Relationship to amaurotic family idiocy? Pediatrics 44: 570–583, 1969.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1975

Authors and Affiliations

  • Reinhard L. Friede
    • 1
    • 2
  1. 1.Case Western Reserve UniversityClevelandUSA
  2. 2.University of ZurichSwitzerland

Personalised recommendations